ArticleBMJ open2024

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.

Craig Rodgers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.